Associate Director, International Market Analytics and Business Intelligence, Parkinson's

Illinois, USA (Hybrid)

$142K/yr – $269K/yrDirector/Executive6+ years expFull time

Posted 3 months ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Drive data-led brand strategy and cross-functional collaboration for AbbVie’s IMABI Parkinson’s assets.

  • Must-have: Minimum 6 years in analytics/market research with healthcare data and global experience.
  • Standout: Influences global and affiliate teams with insights shaping 3–5 year strategy.
  • Own cross-functional initiatives with on-time, within-budget delivery.

Job Description

Responsibilities

  • Serve as the IMABI lead for the Parkinson’s disease assets.
  • Responsible for partnering strategically with International, Area and Affiliate leadership, guiding brand and co positioning strategies. Drive using an insights-led approach and be able to advise on key initiatives based on knowledge of the business and market through data and analytics capabilities.
  • Enable and demonstrate leadership on the cross-functional business teams, International Brand Teams (INBT) and Area and Affiliates, to make better and more rapid business decisions by framing & prioritizing critical brand questions. She/He will need to present interim and end results and communicate all project progress/initiatives to Brand Teams, Senior Management, and/or Vendors, where appropriate.
  • Develop and maintain working relationships with Area and Key Affiliate contacts to co-create and execute plans, eliminate redundancies, and ensure consistency of our market understanding.
  • Influence and motivate Business Intelligence partners in Key Affiliates and play a leading role in the continuous brand planning process based on a deep understanding of the market drivers, patient journey, competition, and positioning, highlighting opportunities to enhance patient and HCP (Health Care Professional) experience.
  • Proactively identify new data sources and analytics opportunities to ensure the INBT decision-making is based on the most current, objective, and comprehensive insights.
  • Lead commercial competitive intelligence to help AbbVie anticipate competitor strategies and achieve market leadership.
  • Provide insights that will shape current dynamics and future market evolution over the next 3-5 years to guide the INBT in the development of successful strategies to maximize both the brand and the market. Identify and utilize reasonable data sources & analytic approaches to measure and evaluate the effectiveness of our core strategies and key initiatives.
  • Lead and participate in initiatives to improve the IMABI data and analytics capabilities.
  • Ensure all IMABI activities are completed on time, within budget, and in accordance with financial and ethical compliance guidelines.
AbbVie logo

AbbVie

4.0 Glassdoor

AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.

Founded in 2013
North Chicago, Illinois, USA
60K employees (3,267 in marketing)
78% recommend to a friend
88% CEO approval

Traffic Signals

Monthly Visitors
1.4M
Monthly Google Ads Budget
$37.3K
Traffic Source Mix
Search
35%
Direct
45.7%
Referral
11.2%
Social
6.1%
Paid
1.8%

Headcount Trend

Current headcount: ~59.9K

Marketing Team

Marketing Team Size
2,942 (5% of company)
Median Career Experience
18 years
Median Tenure
7.3 years
Marketing Roles Posted (Last 30 Days)
42

Funding

Total Funding
$23B
Last Raise
$8B
Post IPO Debt, 18 days ago

Funding History

  • Feb 2026
    Post IPO Debt • $8B
  • Feb 2024
    Post IPO Debt • $15B
  • Mar 2023
    Post IPO Equity • $250K

Recent News